Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 1.85M | 1.1M | 10.32M | 1.13M | 26.01%7.8M | 29.41%6.19M | 4.78M |
| Cost of revenue | 103K | 91K | 389.29K | 97K | 8.72%142.42K | -5.76%131K | 139K |
| Gross profit | 1.74M | 1.01M | 9.93M | 1.03M | 26.38%7.65M | 30.46%6.06M | 4.64M |
| Operating expense | 583K | 448K | 3.63M | 2.38M | 35.61%832.66K | -7.81%614K | 666K |
| Staff costs | ---- | ---- | ---- | ---- | 13.93%368K | -6.65%323K | --346K |
| Selling and administrative expenses | --583K | --448K | --3.63M | --2.38M | 447.80%832.66K | -14.61%152K | --178K |
| -Selling and marketing expense | ---- | ---- | --28.79K | --9K | 159.19%18.14K | 75.00%7K | --4K |
| -General and administrative expense | --583K | --448K | --3.6M | --2.37M | 461.74%814.52K | -16.67%145K | --174K |
| Depreciation and amortization | ---- | ---- | ---- | ---- | 1.64%62K | 10.91%61K | --55K |
| -Depreciation | ---- | ---- | ---- | ---- | 1.64%62K | 10.91%61K | --55K |
| Rent and land expenses | ---- | ---- | ---- | ---- | 22.22%22K | 0.00%18K | --18K |
| Other operating expenses | ---- | ---- | ---- | ---- | 50.00%90K | -13.04%60K | --69K |
| Operating profit | 1.16M | 558K | 6.3M | -1.35M | 25.34%6.82M | 36.87%5.44M | 3.98M |
| Net non-operating interest income (expenses) | 242.86%240K | -10.46%70K | 78.18K | ||||
| Non-operating interest income | ---- | ---- | ---- | ---- | 242.86%240K | -11.39%70K | --79K |
| Non-operating interest expense | ---- | ---- | ---- | ---- | --0 | --0 | --820 |
| Net investment income | |||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | -1K | ||||
| Income from associates and other participating interests | |||||||
| Special income (charges) | |||||||
| Other non-operating income (expenses) | 327K | 75K | 364.63K | 62K | 240.37K | ||
| Income before tax | 1.49M | 633K | 6.66M | -1.29M | 28.13%7.06M | 35.98%5.51M | 4.05M |
| Income tax | 357K | 152K | 2.2M | 227K | 31.38%1.69M | 28.61%1.28M | 998.98K |
| Net income | 1.13M | 481K | 4.46M | -1.51M | 27.14%5.37M | 38.40%4.23M | 3.05M |
| Net income continuous operations | --1.13M | --481K | --4.46M | ---1.51M | 27.14%5.37M | 38.40%4.23M | --3.05M |
| Noncontrolling interests | |||||||
| Net income attributable to the company | 1.13M | 481K | 4.46M | -1.51M | 27.14%5.37M | 38.40%4.23M | 3.05M |
| Preferred stock dividends | |||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1.13M | 481K | 4.46M | -1.51M | 27.14%5.37M | 38.40%4.23M | 3.05M |
| Gross dividend payment | |||||||
| Basic earnings per share | 0.0056 | 0.0024 | 0.0292 | -0.87 | 27.14%0.0265 | 38.40%0.0209 | 0.0151 |
| Diluted earnings per share | 0.0056 | 0.0024 | 0.0292 | -0.87 | 27.14%0.0265 | 38.40%0.0209 | 0.0151 |
| Dividend per share | 0 | 0 | 0.005 | ||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.